Alissa Wilkinson in Vox:

At the press conference following the Cannes premiere of Martin Scorsese’s Killers of the Flower Moon, someone asked Robert De Niro about his character, a kingpin of a sort with a tricky psyche. “It’s the banality of evil,” he said, describing the character’s moral ambiguity. “It’s the thing we have to watch out for. We see it today, of course. We all know who I’m going to talk about, but I’m not going to say his name.” (Everyone knew who he meant.)

The banality of evil was hot at Cannes this year. De Niro’s statement came on the heels of the premiere of Jonathan Glazer’s The Zone of Interest, which set Cannes critics abuzz about the same phrase. That movie — which I proposed might best be understood as an adaptation of Hannah Arendt’s Eichmann in Jerusalem, even more than the Martin Amis novel it’s loosely based on — is not much like Killers of the Flower Moon, at first blush. Glazer’s is short, taut horror that evokes the Holocaust by keeping it offscreen; Scorsese’s is epic, bloody, and relentless in its depiction of a series of murders from a century ago.

Thematically, however, they often rhyme. Both are about mankind’s ability to exterminate one another while deluding themselves into thinking they’re doing the right thing. Both are about atrocities so heinous they’re hard to wrap your mind around. And both feel eerily contemporary, in an age where prejudice, racism, and fascism are on the rise around the globe.

More here.

The Book of Lies

I’d like to have a word
with you. Could we be alone
for a minute? I have been lying
until now. Do you believe

I believe myself? Do you believe
yourself when you believe me? Lying
is natural. Forgive me. Could we be alone
forever? Forgive us all. The word
is my enemy. I have never been alone;
bribes, betrayals. I am lying
even now. Can you believe
that? I give you my word.

by James Tate
from Strong Measures
Harper Collins, 1986

https://www.youtube.com/watch?v=IgnRr170ERM&ab_channel=LibraryVHSRips

Lachlan Carey in Phenomenal World:

Biden’s green industrial strategy is both impressive in scale and in its passage amidst highly complex political circumstances. After fractious negotiations, Congress authorized over $4 trillion in new investment between its four major pieces of economic legislation. Officially, around $500 billion of that spending goes towards climate-related spending, most of which is contained in the Inflation Reduction Act. According to our estimates, the US federal government will spend an average of over $100 billion each year on climate mitigation over the next ten years, about two and a half times the annual average from 2009-2017.

Even this figure is likely a significant underestimate. Since many of the tax credits contained in IRA are uncapped, total public expenditure is limited only by private demand for these incentives. If deployment of key clean energy technologies, such as solar or green hydrogen, were to be in line with a 2050 net-zero pathway, we estimate that total spending in the IRA alone could reach $1 trillion. A recent Brookings analysis reached a similar figure even without the net-zero constraint. This discrepancy is particularly large in renewable energy spending, which could see twice as much spending in a climate-aligned pathway—green hydrogen could see five times the spending, and the electric vehicle (EV) supply chain a staggering ten times the official Congressional Budget Office (CBO) estimates if consumers rush to buy cheaper EVs.

More here.

Stephen Mulhall in the London Review of Books:

For David Edmonds​, and for many other philosophers, Derek Parfit, who died in 2017, was one of the greatest moral thinkers of the past century, perhaps even since John Stuart Mill. Edmonds rightly believes that if Parfit’s ideas about personal identity, rationality and equality were absorbed into our moral and political thinking, they would radically alter our beliefs about punishment, the distribution of social resources, our relationship to future generations, and more. So it’s easy to see why he wants to make Parfit’s ideas more widely known outside the academy. What is less easy to understand is his belief that the best, or even an appropriate, way of achieving this goal is to write a biography of him.

There was a time when biographies of philosophers weren’t just common, but expected and even required. Following Socrates, the great schools of Hellenistic philosophy (the Stoics, the Epicureans, the Neoplatonists) all tried to encourage the pursuit of a certain kind of life. For them, philosophy wasn’t primarily something you learned, but something you practised, with a view to self-transformation. So it was indispensable in critically evaluating a philosopher to critically evaluate their way of life, for that life was the definitive expression of their philosophy, and their writings were primarily a means of achieving that essential work on the self.

More here.

A Boston Review Forum, with a lead piece by Christine Sypnowich:

The last decade has delivered increasingly bleak portraits of vast inequalities in income, wealth, health, and other measures of well-being in many rich capitalist countries, from the United States to the United Kingdom. What should we do about them?

One common response is to argue that inequalities are only a problem to the extent that they reflect unequal opportunities. Economist Jared Bernstein—a longtime advisor to Joe Biden, now a member of the White House Council of Economic Advisers—expressed this view clearly in 2014 when he stated, “Opportunity and mobility are the right things to be talking about. . . . We always have inequality, and in America we’re not that upset about inequality of outcomes. But we are upset about inequality of opportunity.” Accordingly, in his first executive order as president, Biden proclaimed that “equal opportunity is the bedrock of American democracy.” For his part, British Labour leader Keir Starmer has stated his party’s aim should be to “pull down obstacles that limit opportunities and talent.” And Prime Minister Justin Trudeau has intoned that in Canada, where I live, “no matter who you are . . . you have every opportunity to live your life to its fullest potential.”

These statements are typical. In much of the West the tendency is to see equality as a matter of fairly distributed opportunities and to view an interest in outcomes as unreasonable, naïve, or even authoritarian. A similar focus on equality of opportunity is evident in the dominant strain of political philosophy in the Anglo-American world, liberal egalitarianism. In short, the prevailing political common sense tends to converge on the assumption that our egalitarian aspirations are realized once we have ensured equality of opportunity.

I think this view is seriously mistaken.

More here.

Elizabeth Pennsi in Science:

Twice, quarterback Patrick Mahomes has led the Kansas City Chiefs to victory in the Super Bowl, the pinnacle of U.S. football. Although most fans have their eyes on the ball as Mahomes prepares to throw, his tongue does something just as interesting. Just as basketball star Michael Jordan did as he went up for a dunk, and dart players often do as they take aim for a bull’s-eye, Mahomes prepares to pass by sticking out his tongue. That may be more than a silly quirk, some scientists say. Those tongue protrusions may improve the accuracy of his hand movements.

A small but growing group of researchers is fascinated by an organ we often take for granted. We rarely think about how agile our own tongue needs to be to form words or avoid being bitten while helping us taste and swallow food. But that’s just the start of the tongue’s versatility across the animal kingdom. Without tongues, few if any terrestrial vertebrates could exist. The first of their ancestors to slither out of the water some 400 million years ago found a buffet stocked with new types of foods, but it took a tongue to sample them. The range of foods available to these pioneers broadened as tongues diversified into new, specialized forms—and ultimately took on functions beyond eating.

More here.

Roger Rosenblatt in The New York Times:

Ah, the magical season of prizes is once again upon us. Each spring brings, along with warm rains and budding flowers, Fulbrights, Rhodeses, Pulitzers and Guggenheims, as well as Oscars, Tonys and Indies — which are thought of so fondly they come with their own nicknames. Everybody, it seems, loves honors and prizes. And they certainly make for great entertainment. The award ceremonies for literary prizes are usually demure, decorous little things, but award shows on TV are like a country music hoedown. And the Oscars rank so high in the culture that actors measure their worth by rehearsing their acceptance speeches.

Is there anything seriously wrong with all of this? Not that I can see. Winning a prize is an undeniably thrilling, magical thing. It is, in essence, the world’s way of telling you that you’ve done something noteworthy and valuable. It’s your moment to shine. But on the whole, do prizes do any good? Are they shallow or meaningful? Motivating or stultifying? Would the minds and achievements of Copernicus, Galileo, Vermeer or van Gogh have suffered chilling effects from winning prizes? What if Beethoven had squatted on his haunches after receiving a lifetime achievement award for his Fourth Symphony?

More here.

Kenneth W Mack at The Guardian:

Who was the Rev Martin Luther King Jr? In America, the civil rights activist and Baptist minister is now embraced across the political spectrum even as the teaching of the history of discrimination and segregation that shaped him is being actively suppressed in many parts of the country. Beyond the US, he is widely celebrated in nations confronting difficult questions about their own racial pasts.

At the time of his assassination in 1968, however, most Americans had a negative view of him, and the National Security Agency had tapped his overseas phone calls. As late as the 1980s, President Ronald Reagan could state that it was still an open question whether he had been a communist dupe, as King’s enemies at J Edgar Hoover’s FBI had long alleged. By the end of that decade, however, with a national holiday in his honour (reluctantly assented to by Reagan) and prize-winning biographies by Taylor Branch and David Garrow in print, King’s image had undergone a remarkable transformation.

more here.

Question

Body my house
my horse my hound
what will I do
when you are fallen

Where will I sleep
how will I ride
What will I hunt

Where can I go
without my mount
all eager and quick
How will I know
in thicket ahead
is danger or treasure
when Body my good
bright dog is dead

How will it be
to lie in sky
without roof or door
and wind for an eye

With cloud for shift
how will I hide?

by May Swenson
from Strong Measures
Harper Collins, 1986

Solcyre Bulga in Time:

When Tina Turner died on Wednesday after a half-century career full of legendary anthems, many remembered her as the “Queen of Rock ‘n’ Roll.” But the chart-topping hit for which she will perhaps be most remembered isn’t a rock song—and that fact almost got in the way of the song ever being released. “What’s Love Got to Do With It,” which debuted in 1984, spent 28 weeks on the Billboard chart—including three at No. 1, making it one of just six top-10 hits from Turner’s solo career. The single went gold, and the album on which it appeared topped 5 million units sold; the song also provided the title for a Turner biopic of the same name, for which lead actress Angela Bassett was nominated for an Oscar.

But “What’s Love Got To Do With It” was different from Turner’s previous hits.

Rob Stein on NPR:

Researchers are inching closer to mass-producing eggs and sperm in the lab from ordinary human cells. The technique could provide new ways to treat infertility but also open a Pandora’s box.

ROB STEIN, BYLINE: It’s a Wednesday morning at the National Academies of Sciences, Engineering, and Medicine in downtown Washington, D.C.

ELI ADASHI: Welcome, everybody, to the National Academy of Medicine workshop.

STEIN: Dr. Eli Adashi from Brown University opens the Academy’s first gathering to explore the latest scientific developments and complicated social implications of something known as in vitro gametogenesis, or IVG, which involves making human eggs and sperm in the laboratory from any cell in a person’s body.

ADASHI: It is on the precipice of materialization, and IVF will probably never be the same.

STEIN: Japanese scientists describe how they’ve already done this in mice, coaxing cells from the tails of adult mice to become what’s known as induced pluripotent stem cells, or IPS cells, and then coaxing those cells to become mouse sperm and eggs. They’ve even used those sperm and eggs to make embryos and implanted the embryos into the wombs of female mice, which gave birth to apparently healthy mouse pups. Mitinori Saitou joins the workshop via Zoom from Kyoto University.

More here.

Maxwell Strachan in Vice:

After 35 years of living in relative control of my decisions, I had decided to see what would happen if I asked AI to control my life instead. Years of suboptimal performance, both personally and professionally, and numerous failed attempts at self-improvement had convinced me there had to be a better way, and I wondered if the collective knowledge hidden inside OpenAI’s hit tech product could help me. But when I asked Sam Altman’s ChatGPT to become my all-powerful leader, it seemed reticent, at least at first.

“While I appreciate your willingness to explore new possibilities, I must emphasize that I cannot truly take control of your life or make decisions on your behalf,” ChatGPT said as it ominously labeled our conversation “Control Your Life.” As someone who was hoping to have his entire life controlled by AI, I found the answer frustrating.

More here.

O, Scallion!

The first time I cut into a scallion,
I leapt back, watching it splinter
into a thousand translucent Os
that skipped across the counter
like flecks of young jade.
I was enamored by its crinkle,
its staticky scrunch. How it
doubled over, limp,
in a melodramatic act of being
O so done with this world. Its
rubbery stems, capped in mottled
whiskery faces, like a deep-sea
bottom feeder, gasping as soon as
pulled from dark moist. I marveled:
O, tenacious green, teenage
zest. Skins that smear
in protest against board
when knife is too dull.
O, child of spring, ripped from home
far too soon, dug up for babyish
bulbs, your final form forgotten.
I confess, I sometimes falter when
you’re tucked between cousins
in camouflage of leek, shallot, chive—
and then I swore
to one day snip
a fistful of scallions
right at the end
of their hollowness,
stand them
in shallow water
and witness how,
when allowed to,
unfettered and alone,
they bloom.

by Sofia Koyama
from Brooklyn Poets

Mariana Lenharo in Nature:

A new generation of drugs is revolutionizing the treatment of obesity and astonishing researchers with their potency. The drug semaglutide, for example, enabled one-third of clinical-trial participants to shed at least 20% of their body weight¹. Tirzepatide, a competing therapy, achieved similar results in more than half of study participants².

Despite their high effectiveness, researchers are learning that these drugs are not necessarily the solution for everyone living with obesity. “Everybody wants to try them but not everyone responds to them,” says Andres Acosta, an obesity specialist at Mayo Clinic in Rochester, Minnesota. Now that semaglutide and tirzepatide have been around for some time, health-care providers are beginning to identify who is likely to benefit the most from them — and to recognize challenges in the drugs’ use.

More here.